Funder: NIH: Office of Strategic Coordination

This FOA solicits applications responsive only to the COVID-19 public health emergency through support of the CARES Act. All other Transformative Research Award applications must be submitted in response to RFA-RM-20-013.

Due to the COVID-19 public health emergency, the Common Fund will dedicate funds provided by the CARES Act to support a total of 5-10 Transformative Research Awards (through this FOA) or Early Independence Awards (through RFA-RM-20-021) that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics. As with all High-Risk, High-Reward Research program applications, innovation may be technological or conceptual.

Topics: Applied Research, Biomarkers, Clinical Presentation of Infection, Clinical Trial, Co-Morbidities, Community Engagement, Computational Analysis, Diagnostics, Antibody Detection, Viral Detection, Economic Impact, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Risk Factors, Transmission, Health Disparities, Healthcare Implementation, Immunology, Host Factors, Host Response, Mental Health, Psychology, Mobile Health, Organ, Prevention, PPE, Prognostics, Research Model Development, Mouse Models, Organoid Models, Research Tool Development, Research Site, International, Treatments, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Treatment, Drugs, Immunological Response Targets, Vaccines, Viral Interactome, Virus Biology